Influenza Vaccine in Lung Transplant Patients - Seroprotection

Completed

Conditions studied: Influenza

In brief

This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate two different definitions of influenza vaccine seroprotection at mid-season in lung transplant patients.

Key facts

Study ID

NCT04531657

Run by

University of Wisconsin, Madison

People needed

79

Starts

2004-12-01

Expected to finish

2009-07-01

Last updated by the study team

2020-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Receiving care post-lung transplant at University of Wisconsin Hospital
• Healthy adult

You may not qualify if…

• Allergy to eggs
• Moderate to severe febrile illness
• Active treatment for acute rejection
• Received season's influenza vaccine prior to enrollment

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.